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Abstract
There are several reports that vouch for the usefulness of diffusion-weighted image (DWI) in making a diagnosis before 
treatment. However, no study has evaluated the effect of radiotherapy (RT) for unresectable gastric cancer. In the present case 
report, we evaluated the effectiveness of RT using DWI. An 81-year-old man was hospitalized with a broken bone and then 
diagnosed with advanced gastric cancer with breeding. He had chorionic renal failure and surgery was impossible. Further, 
contrast-enhanced computed tomography and magnetic resonance imaging (MRI) were not performed due to renal failure, 
whereas palliative RT was performed. We followed up the patient using blood test and MRI (DWI) to estimate whether 
bleeding had stopped or not after radiotherapy. Hemostasis effect was found after 2 weeks of RT. In DWI examination, 
there was a decrease in the tumor signal intensity 30 days after RT. Similarly, at day 60, the tumor signal intensity further 
decreased on DWI and the blood test results indicated no progression of anemia. At 4 months after the RT, the patient died 
because of respiratory failure without any bleeding. DWI is useful not only for the initial diagnosis but also for evaluating 
the effectiveness of RT.
Trial registration: National clinical study registered number: UMIN000026362.
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Introduction
Magnetic resonance imaging (MRI) has been increasingly 
used to evaluate the stage of solid cancer and to determine 
the therapeutic effect, particularly with the aid of diffusion-
weighted imaging (DWI) [1–6]. The technique is applied for 
staging the disease prior to commencing the treatment for 
gastric cancer. Recently, the use of DWI has been reported 
as an effect of treatment by RT and chemotherapy for solid 
cancer. However, to the best of our knowledge, there is no 
report that estimated the treatment effect of RT on the gas-
trointestinal tract [4–6]. In the present case report of gastro-
intestinal tract cancer, we evaluated the effectiveness of RT 
using DWI.
Case report
An 81-year-old man was hospitalized with a broken bone 
and then diagnosed with advanced gastric cancer. The condi-
tion was endoscopically diagnosed as adenocarcinoma with 
Bormann type 3 with bleeding (Fig. 1). The patient under-
went plain computed tomography (CT) because his renal 
function was compromised and contrast agents could not 
be used. CT revealed surrounding lymph node metastasis, 
pancreatic invasion, and left adrenal metastasis. His tumor 
was inferred to be unresectable.
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Plain CT (16-row multidetector CT; Alexion, Toshiba 
Medical System; Otawara, Japan) and MRI (MRI, Achieva; 
Philips Medical Systems, Best, The Netherlands) were used 
to investigate the extent of tumor development. Parameters 
for CT were as follows: slice thickness of 2 mm, field of 
view of 50 × 50 cm, and settings of 150 mA and 120 kV. 
Parameters for T2-weighted imaging (T2-WI) were as fol-
lows: fast spin-echo; repetition time (TR)/echo time (TE) in 
ms: 433/80; number of sample (signals) averaged (NSA): 1; 
and matrix: 256 × 204.
Parameters for DWI were as follows: gradient echo; TR/
TE in ms: 1200/65; NSA: 5; matrix: 80 × 142; and B-value: 
1000. The signal intensity in the gastric wall on DWI was 
checked and compared with that in the spleen before RT (day 
0), immediately after RT (day 5), 30 days after RT (day 30), 
and 60 days after RT (day 60).
The patient was incapable of receiving chemotherapy 
owing to chronic renal failure. Bleeding from the stomach 
could not be controlled by endoscopic treatment. There-
fore, 20 Gy/5 fx of RT (Elekta Synergy System, Elekta 
Ltd, Crawley, UK) was administered. The extent of tumor 
spread could not be accurately measured; the entire outer 
Fig. 1  a Plain CT; The margin of the gastric wall was delineated. b 
T2-weighted image; Moderate increase in the signal intensity in the 
margin of the gastric wall. c Diffusion-weighted image; High signal 
intensity in the margin of the gastric wall. d Upper gastrointestinal 
endoscopy; Gastric cancer with bleeding. Bormann type 3
Fig. 2  Radiotherapy planning; Contouring of the entire outer wall 
of the stomach. From the contoured line, the clinical target volume 
(CTV) was contoured with a 1-cm margin from the outer wall of the 
stomach (yellow line) and the planning target volume (PTV) was con-
toured with a 1-cm margin from the CTV (red line)
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wall of the stomach was contoured. From the contoured 
line, the clinical target volume (CTV) was delineated with 
a 1-cm margin from the outer wall of the stomach and the 
planning target volume (PTV) was contoured with a 1-cm 
margin from the CTV (Fig. 2).
There were no changes in the tumor signal intensity 
on DWI before and 5 days after RT (Fig. 3a, b). Follow-
ing RT, we confirmed for 2 weeks that the hemoglobin 
level did not decrease below the normal limit. We decided 
to administer hemostasis irradiation to which the patient 
responded. At day 30, there was a decrease in the tumor 
signal intensity on DWI (Fig. 3c, d). Similarly, at day 
60, the tumor signal intensity further decreased on DWI 
(Fig. 4) and the blood test results indicated no progression 
of anemia.
During endoscopy, the tumor was ulcerated and flattened 
(Fig. 4c). Subsequently, he was discharged from the hospital; 
however, he was hospitalized with anorexia after 4 months 
of treatment. Plain CT revealed pneumonia and pleural effu-
sion. Endoscopy revealed minimal bleeding from the tumor 
that did not necessitate blood transfusion. We continued to 
provide palliative care, and at 4 months after the initial RT, 
the patient died because of respiratory failure without any 
bleeding.
Discussion
In Japan, gastric cancer is the second prevalent cancer fol-
lowed by colorectal cancer. Surgery and pre- or postopera-
tive chemotherapy are common treatment choices for gastric 
cancer [7, 8]. However, in advanced cases, it is often impos-
sible to perform surgery. Besides, in the event of bleeding, 
endoscopic treatment is often difficult. Therefore, hemo-
stasis irradiation is preferred [9–11]. Various authors have 
reported a response rate of 70–90%, which is quite effective 
for palliative treatment [12].
We performed hemostasis irradiation on patients who 
could not tolerate contrast agents or chemotherapy owing 
to decreased renal function. RT results in tumor cell death 
Fig. 3  a T2-weighted image; Moderate increase in the signal inten-
sity in the margin of the gastric wall. b Diffusion-weighted image; 
High signal intensity in the margin of the gastric wall. There was no 
obvious change in the signal intensity before RT on comparison with 
the spleen’s intensity. c T2-weighted image; No obvious change com-
pared with that in a previous study. d Diffusion-weighted image; The 
signal intensity in the gastric wall decreased in comparison to that in 
a previous study
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and apoptosis, which correlates with an increase in the value 
of the apparent diffusion coefficient (ADC) [13–15]. DWI 
is routinely used for staging the disease before treatment, 
especially in malignant lymphoma and cancers of the head 
and neck, lungs, and esophagus.
ADC serves as a functional biomarker allowing indi-
vidual adaptive therapy based on the observed response. 
We did not obtain the ADC map because it is prepared 
only for solid organs, such as the liver and pancreas. How-
ever, measuring the ADC value of the gastric wall was a 
better option and it would have to be estimated by quan-
titative analysis. In the present study, we did not estimate 
ADC value; therefore, the signal intensity of the gastric 
wall was estimated using a contrast of the signal intensity 
of the spleen. It would be better to measure whether the 
ADC changed with visual recognition to yield quantita-
tive results. There are several reports that vouch for the 
usefulness of DWI in making a diagnosis before treatment 
[13, 14]. There is also a report that DWI can be used for 
cancer staging, such as (18)fluoro-deoxyglucose positron 
emission tomography/CT. We previously documented that 
DWI is beneficial in determining the therapeutic effect 
of radiation chemotherapy in head and neck cancer [15]. 
Unlike CT, DWI does not require contrast media, and a 
hybrid of a tissue can be identified using DWI. Although 
only the surface of the gastric inner wall can be observed 
with the endoscope, evaluation of the stomach wall is also 
possible using MRI. Bleeding increases as the tumor vol-
ume increases. DWI reflects the diffusion limitation of the 
analyzed tissue. When the tumor is damaged by radiation, 
the tumor volume decreases, resulting in decreased diffu-
sion limitation and changed signals on the image.
The stomach is a moving organ and is thus difficult to 
assess with an imaging modality, such as MRI. However, 
in the present case, the stomach was emptied and peristaltic 
movement was suppressed by butylscopolamine. Therefore, 
the form of the stomach could be maintained and reproduc-
ibility of the examination could be enhanced. We followed 
this approach in every RT and succeeded in performing 
hemostasis irradiation.
Because endoscopic examination is an invasive proce-
dure, non-invasive follow-up is desirable after palliative 
Fig. 4  a Plain CT; The margin of the gastric wall reduced in compari-
son to that in a previous study. b T2-weighted image; The margin of 
the gastric wall was reduced in comparison to that in a previous study. 
c Upper gastrointestinal endoscopy; Gastric cancer was minimized 
as compared to that before radiotherapy. Ulcer and flat surface was 
observed. d Diffusion-weighted image; The signal intensity in the 
gastric wall was decreased in comparison to that in a previous study
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treatment. Plain CT is advantageous owing to its rapid scan-
ning (approximately 2–3 s) and as it is rarely influenced by 
the movement of organs; however, it cannot detect biological 
changes. To overcome this disadvantage, MRI can be used 
for estimation of biological changes. Moreover, in situations 
wherein contrast-enhanced CT or MRI cannot be performed, 
DWI is useful in evaluating the effect of treatment, espe-
cially in gastric cancer. Alternatively, the degree of bleed-
ing may be evaluated using a blood test. Nevertheless, it is 
difficult to distinguish gastric bleeding from that in other 
organs. Moreover, when a contrast agent cannot be used 
owing to renal failure, it is difficult to accurately assess with 
plain CT. In such instances, DWI is useful not only for the 
initial diagnosis but also for evaluating the effectiveness of 
RT. Besides, endoscopy is an invasive technique, and appli-
cation of further invasive examination should be avoided. 
DWI reflects the decreased tumor size in solid cancers such 
as lung, head and neck, and prostate cancer. However, there 
was no report regarding the estimation of change in tumor 
size in gastric cancer using DWI after RT. We examined 
effectiveness of RT as clinical trial of DWI for hemostasis 
RT without endoscopy following RT is ongoing. If DWI can 
become an alternative to endoscopy, it will prove useful for 
end-stage patients.
Although DWI has long been considered useful for solid 
cancer, it has been useful for preoperative evaluation of con-
ditions such as lymph node metastasis in the gastrointestinal 
tract. In addition, it has been used more frequently in the 
judgment of curative effects of radical chemotherapy of can-
cer such as esophageal cancer. Because there are currently 
few reports on gastrointestinal cancer treated by palliative 
hemostasis RT, additional cases are required in the future.
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